BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 20189993)

  • 1. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition.
    Yan W; Cao QJ; Arenas RB; Bentley B; Shao R
    J Biol Chem; 2010 Apr; 285(18):14042-51. PubMed ID: 20189993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
    Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
    J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentially expressed genes associated with the metastatic phenotype in breast cancer.
    Kirschmann DA; Seftor EA; Nieva DR; Mariano EA; Hendrix MJ
    Breast Cancer Res Treat; 1999 May; 55(2):127-36. PubMed ID: 10481940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.
    Rezaei M; Friedrich K; Wielockx B; Kuzmanov A; Kettelhake A; Labelle M; Schnittler H; Baretton G; Breier G
    Breast Cancer Res; 2012 Dec; 14(6):R154. PubMed ID: 23216791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cells.
    Sehrawat A; Singh SV
    Cancer Prev Res (Phila); 2011 Jul; 4(7):1107-17. PubMed ID: 21464039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
    Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
    J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of DCIS to invasive breast cancer progression by Singleminded-2s (SIM2s).
    Scribner KC; Behbod F; Porter WW
    Oncogene; 2013 May; 32(21):2631-9. PubMed ID: 22777354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the value of GATA3 combined with E-cadherin in the diagnosis of breast cancer.
    Luo M; Huang Y; Huang J; Huang S; Wei L; Zhang Y; Zhang Z
    J BUON; 2019; 24(3):1038-1044. PubMed ID: 31424658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
    Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
    Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
    Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
    Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of FOXQ1 in benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells.
    Sehrawat A; Kim SH; Vogt A; Singh SV
    Carcinogenesis; 2013 Apr; 34(4):864-73. PubMed ID: 23276794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
    Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
    Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
    Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
    BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
    Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
    Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing of malignancy of breast cancer cells after cryopreservation: molecular detection and activation of angiogenesis after CAM-xenotransplantation.
    Du X; Todorov P; Isachenko E; Rahimi G; Mallmann P; Meng Y; Isachenko V
    BMC Cancer; 2020 Aug; 20(1):753. PubMed ID: 32787800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of E- and P-cadherin in invasive breast cancer cells.
    Sarrió D; Palacios J; Hergueta-Redondo M; Gómez-López G; Cano A; Moreno-Bueno G
    BMC Cancer; 2009 Mar; 9():74. PubMed ID: 19257890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.
    Sullivan NJ; Sasser AK; Axel AE; Vesuna F; Raman V; Ramirez N; Oberyszyn TM; Hall BM
    Oncogene; 2009 Aug; 28(33):2940-7. PubMed ID: 19581928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.